NR566 NR 566 ADVANCED
PHARMACOLOGY FAMILY CARE
FINAL EXAM 2026 COMPREHENSIVE
STUDY PACK QUESTIONS ANSWERS
A+
◉ IBS-C.
Answer: Constipation-predominant subtype of Irritable Bowel
Syndrome.
◉ IBS-D.
Answer: Diarrhea-predominant subtype of Irritable Bowel Syndrome.
◉ IBS-M.
Answer: Mixed subtype of Irritable Bowel Syndrome, characterized by
alternating symptoms.
◉ Clinical Presentation of IBS.
Answer: Recurrent abdominal pain (relieved with defecation), bloating,
distention, altered stool form/frequency, mucus in stool, no weight loss,
bleeding, or systemic signs.
◉ Management of IBS.
,Answer: Avoid triggers (lactose, caffeine, FODMAPs), gradual fiber
increase, stress management, regular meals, hydration, and medications
such as antispasmodics.
◉ Ulcerative Colitis (UC).
Answer: Inflammatory bowel disease affecting the colon only,
characterized by mucosal layer inflammation.
◉ Crohn's Disease (CD).
Answer: Inflammatory bowel disease that can affect any part of the GI
tract, characterized by transmural inflammation and patchy 'skip' lesions.
◉ Symptoms of Ulcerative Colitis.
Answer: Bloody diarrhea, urgency, abdominal pain.
◉ Symptoms of Crohn's Disease.
Answer: Diarrhea, weight loss, malnutrition.
◉ Complications of Ulcerative Colitis.
Answer: Toxic megacolon, colon cancer.
◉ Complications of Crohn's Disease.
Answer: Fistulas, strictures, malabsorption.
, ◉ Colorectal Cancer (CRC).
Answer: Malignant growth in colon or rectum from adenomatous
polyps.
◉ Symptoms of Colorectal Cancer.
Answer: Rectal bleeding, iron-deficiency anemia, weight loss, change in
bowel habits, abdominal discomfort.
◉ Colonoscopy.
Answer: Gold standard diagnostic tool for colorectal cancer.
◉ Colorectal Cancer Screening Recommendations.
Answer: Colonoscopy every 10 years starting at age 45 for average risk;
every 5 years starting before 45 for higher risk.
◉ GERD Differential Diagnoses.
Answer: Peptic ulcer disease, esophageal motility disorder, esophageal
cancer, nonulcer dyspepsia, cardiac issues, eosinophilic esophagitis,
hiatal hernia.
◉ Pharmacologic Management of GERD.
Answer: Antacids, H2 blockers, PPIs; avoid long-term use due to risks.
◉ Common Differentials for Nausea and Vomiting.
PHARMACOLOGY FAMILY CARE
FINAL EXAM 2026 COMPREHENSIVE
STUDY PACK QUESTIONS ANSWERS
A+
◉ IBS-C.
Answer: Constipation-predominant subtype of Irritable Bowel
Syndrome.
◉ IBS-D.
Answer: Diarrhea-predominant subtype of Irritable Bowel Syndrome.
◉ IBS-M.
Answer: Mixed subtype of Irritable Bowel Syndrome, characterized by
alternating symptoms.
◉ Clinical Presentation of IBS.
Answer: Recurrent abdominal pain (relieved with defecation), bloating,
distention, altered stool form/frequency, mucus in stool, no weight loss,
bleeding, or systemic signs.
◉ Management of IBS.
,Answer: Avoid triggers (lactose, caffeine, FODMAPs), gradual fiber
increase, stress management, regular meals, hydration, and medications
such as antispasmodics.
◉ Ulcerative Colitis (UC).
Answer: Inflammatory bowel disease affecting the colon only,
characterized by mucosal layer inflammation.
◉ Crohn's Disease (CD).
Answer: Inflammatory bowel disease that can affect any part of the GI
tract, characterized by transmural inflammation and patchy 'skip' lesions.
◉ Symptoms of Ulcerative Colitis.
Answer: Bloody diarrhea, urgency, abdominal pain.
◉ Symptoms of Crohn's Disease.
Answer: Diarrhea, weight loss, malnutrition.
◉ Complications of Ulcerative Colitis.
Answer: Toxic megacolon, colon cancer.
◉ Complications of Crohn's Disease.
Answer: Fistulas, strictures, malabsorption.
, ◉ Colorectal Cancer (CRC).
Answer: Malignant growth in colon or rectum from adenomatous
polyps.
◉ Symptoms of Colorectal Cancer.
Answer: Rectal bleeding, iron-deficiency anemia, weight loss, change in
bowel habits, abdominal discomfort.
◉ Colonoscopy.
Answer: Gold standard diagnostic tool for colorectal cancer.
◉ Colorectal Cancer Screening Recommendations.
Answer: Colonoscopy every 10 years starting at age 45 for average risk;
every 5 years starting before 45 for higher risk.
◉ GERD Differential Diagnoses.
Answer: Peptic ulcer disease, esophageal motility disorder, esophageal
cancer, nonulcer dyspepsia, cardiac issues, eosinophilic esophagitis,
hiatal hernia.
◉ Pharmacologic Management of GERD.
Answer: Antacids, H2 blockers, PPIs; avoid long-term use due to risks.
◉ Common Differentials for Nausea and Vomiting.
